GLUT4 Cancer Research Results
GLUT4, Glucose Transporter 4: Click to Expand ⟱
| Source: |
| Type: |
GLUT4 (Glucose Transporter 4) is a protein that plays a crucial role in glucose metabolism by facilitating the transport of glucose across cell membranes. GLUT4 is a member of the facilitated glucose transporter family and is primarily expressed in adipose tissue and skeletal muscle.
GLUT4 has been shown to be overexpressed in many types of tumors, and its expression has been linked to cancer cell growth, survival, and metastasis.
GLUT4 is involved in the regulation of glucose metabolism in cancer cells, and its overexpression has been shown to promote glucose uptake and energy production in cancer cells.
GLUT4 promotes glucose uptake and energy production in cancer cells.
GLUT4 expression is linked to poor prognosis in various types of cancer.
|
Scientific Papers found: Click to Expand⟱
*CEBPA↓, Figure 2
*PPARγ↓,
*FASN↓,
*SREBP1↓,
*FABP4↓,
*GLUT4↓,
*β-catenin/ZEB1↑, Boron Activated the β-Catenin Signaling Pathway
*MMP2↓, As shown in Fig. 6, soluble transforming growth factor receptor 1 (sTNFR1) and matrix metalloproteinase 2
(MMP2) protein levels decreased in the presence of boron
*FGF↑, whereas basic fibroblast growth factor expression (bFGF) increased
*Ca+2?, Boric acid has been reported to interact with NAD + and inhibit cyclic ADP ribose-activated Ca 2+ release from ryanodine receptor, leading to decreased endoplasmic reticulum luminal Ca 2+ concentrations
GlucoseCon↓, decreased glucose absorption
ATP↓,
HIF-1↓,
GLUT1↓,
GLUT4↓,
HK2↓,
LDHA↓,
ERK↓,
Akt↓,
Apoptosis↑,
NF-kB↓,
ROS↑, increases ROS production
Bax:Bcl2↑,
MMP↓,
Casp3↑,
Casp9↑,
p‑JNK↓,
Hif1a↓,
NF-kB↓,
GLUT1↓,
GLUT4↓,
HK2↓,
LDHA↓,
TumCCA↑, G0/G1 cell cycle arrest
TumMeta↓,
GlucoseCon↓, 5%-20% of control for glucose uptake
ATP↓,
necrosis↑, cells incubated with Graviola extract have a gain in cell volume, a characteristic of necrotic cell death
Casp∅, Caspase-3 expression values remained statistically unaltered by treatment with the extract, suggesting that apoptotic pathways are not involved
p‑FAK↓,
MMP9↓,
MUC4↓, significant downregulation in MUC4
EGFR↓,
PI3K/Akt↓,
NF-kB↓,
JAK↓,
STAT↓,
Hif1a↓, inhibition of HIF-1α, GLUT1, and GLUT4 [
GLUT1↓,
GLUT4↓,
ROS↑, generation of reactive oxygen species (ROS) via upregulatoin of enzyme systems like catalase (CAT), superoxide dismutase (SOD), and heme-oxygenase (HO-1) expression
Catalase↑,
SOD↑,
HO-1↑,
EGFR↓,
cycD1/CCND1↓,
Bcl-2↓,
TumCCA↑, G1 cell cycle arrest, 2nd ref :G0/G1 phase cell arrest
Apoptosis↑,
ROS↑,
MMP↓,
BAX↑,
Cyt‑c↑, cytochrome c release
Hif1a↓,
NF-kB↓,
GLUT1↓,
GLUT4↓,
HK2↓,
LDHA↓,
ATP↓,
Hif1a↓, PCa downregulation of HIF-1α, GLUT1, GLUT4, HK2 and LDHA; decreased cell motility and invasion by downregulating MUC4
GLUT1↓,
GLUT4↓,
HK2↓,
LDHA↓,
MUC4↓,
TumCCA↑, Hematological malignancies, cell cycle arrest, loss of MMP
MMP↓,
NF-kB↓, graviola treatment suppresses nuclear factor-κB (NF-κB) signaling, induces reactive oxygen species (ROS) production and increases the Bax/Bcl-2 ratio–mediated attenuation of mitochondrial membrane potential (MMP), cytosolic cytochrome c and caspase-3
ROS↓,
Bax:Bcl2↑,
ER(estro)↓, graviola inhibited the growth of MCF-7 breast cancer cells by decreasing estrogen receptor (ER), cyclin D1 and antiapoptotic gene Bcl2 expression in cell lines and xenografts
cycD1/CCND1↓,
chemoPv↑, Graviola extracts have also been used as chemopreventive agent in many carcinogen-induced mouse models
hepatoP↑, Annona muricata is commonly used to treat several liver disorders, particularly jaundice.
TumCG↓,
LC3II↑,
p62↓,
ATP↓,
Pyruv↓,
GlucoseCon↑, promoted glucose uptake
HK2↓,
PFK1↓,
GLUT4↓,
Glycolysis↓,
JAK2↓,
p‑STAT3↓,
p‑STAT5↓,
Showing Research Papers: 1 to 7 of 7
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Catalase↑, 1, HO-1↑, 1, ROS↓, 1, ROS↑, 3, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 4, MMP↓, 3,
Core Metabolism/Glycolysis ⓘ
GlucoseCon↓, 2, GlucoseCon↑, 1, Glycolysis↓, 1, HK2↓, 5, LDHA↓, 4, PFK1↓, 1, PI3K/Akt↓, 1, Pyruv↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 2, BAX↑, 1, Bax:Bcl2↑, 2, Bcl-2↓, 1, Casp∅, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, p‑JNK↓, 1, necrosis↑, 1,
Autophagy & Lysosomes ⓘ
LC3II↑, 1, p62↓, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 2, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, STAT↓, 1, p‑STAT3↓, 1, p‑STAT5↓, 1, TumCG↓, 1,
Migration ⓘ
p‑FAK↓, 1, MMP9↓, 1, MUC4↓, 2, TumMeta↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 2, HIF-1↓, 1, Hif1a↓, 4,
Barriers & Transport ⓘ
GLUT1↓, 5, GLUT4↓, 6,
Immune & Inflammatory Signaling ⓘ
JAK↓, 1, JAK2↓, 1, NF-kB↓, 5,
Hormonal & Nuclear Receptors ⓘ
ER(estro)↓, 1,
Clinical Biomarkers ⓘ
EGFR↓, 2,
Functional Outcomes ⓘ
chemoPv↑, 1, hepatoP↑, 1,
Total Targets: 51
Pathway results for Effect on Normal Cells:
Core Metabolism/Glycolysis ⓘ
FABP4↓, 1, FASN↓, 1, PPARγ↓, 1, SREBP1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
CEBPA↓, 1, FGF↑, 1,
Migration ⓘ
Ca+2?, 1, MMP2↓, 1, β-catenin/ZEB1↑, 1,
Barriers & Transport ⓘ
GLUT4↓, 1,
Total Targets: 10
Scientific Paper Hit Count for: GLUT4, Glucose Transporter 4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:774 State#:% Dir#:1
wNotes=on sortOrder:rid,rpid
Home Page